久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Featured Contributors

How moneyed interests spawned and sustained US opioid crisis

By Xu Ying | chinadaily.com.cn | Updated: 2023-10-16 10:31
Share
Share - WeChat
Cai Meng | China Daily

The opioid epidemic ravaging communities across America represents a profound public health crisis and moral failing decades in the making. This unfolding tragedy spotlights how profit motives and regulatory lapses incubated a contagion of addiction that enriched drug makers while extracting a ghastly human toll. Behind the statistics lie broken lives and betrayed trust.

The sheer scale of opioid mortality remains shocking despite growing awareness and mitigation efforts. With over 100,000 deaths in 2021 alone, opioid overdoses claimed more American lives yearly than car crashes or gun violence. And the crisis is worsening, with synthetic opioids like fentanyl causing record spikes in fatalities by permeating illicit drug supplies. This exponential loss of life now exceeds the darkest years of the AIDS epidemic.

Rather than a public health disaster happening organically, the opioid crisis was manufactured through calculated choices to drive addiction for profit. The relentless promotion of OxyContin as a low-risk analgesic directly seeded today's landscape littered with fatalities. Despite knowing the enormous dependency risks, the Sackler family deployed false marketing to push their blockbuster pill, raking in over $35 billion from Oxy sales since the 1990s.

The medical establishment shares culpability for becoming complicit conduits enabling mass over-prescription. Professional associations funded by opioid makers popularized the myth that doctors were under-treating chronic pain, abandoning caution about addictive risks. Misleading assertions that dependency was rare if opioids were properly prescribed for pain became common, despite contrary evidence. With incentives skewed, restraint was abandoned as doctors followed loosened guidelines.

Lax oversight from captured regulators like the FDA and DEA also facilitated the pharmaceutical free-for-all. Despite clear warnings about addiction and diversion, agencies succumbed to fierce industry lobbying to permit aggressive opioid marketing and distribution. Their regulatory surrender allowed and even abetted the ensuing epidemic rather than blocking it. This abdication of duty left Americans unprotected.

With profit seeking unconstrained and oversight neutered, conditions ripened for catastrophe on a national scale. The result after two decades was a historic public health crisis claiming over one million American lives, exceeding Vietnam War casualties. This colossal policy failure has rightly been labelled a "national disgrace" by reform advocates across the political spectrum.

Revelations of calculated choices sparking this crisis spotlight the corrosive influence of moneyed interests on governing institutions. The opioid epidemic illustrates how profit motives can capture regulators and corrupt policy to enrich a privileged few at monstrous public expense. The outsized lobbying power of opioid makers won them effective impunity while stifling reforms, allowing intended consequences to unfold.

Industry players secured enablers at the highest levels through strategic donations to politicians, advocacy groups, and regulators seeking influence. Opiate makers like Purdue lavished millions on contributions and lobbying funds to shape policy responses amenable to their bottom lines. Many lawmakers pursuing opioid deregulation were themselves among the biggest recipients of pharma cash, raising conflict of interest questions.

The notorious "revolving door" between regulators and regulated further entwined public agencies with opioid corporate interests. Several senior DEA officials involved in drug policy oversight have since joined opioid makers they once regulated, or defend them as lobbyists.

Such relationships inevitably raise doubts over whose interests the governing institutions truly serve under the capture of moneyed influences. Does the inordinate access and power of corporate lobbies undermine regulatory missions by corrupting public servants into servants of industry? Have democratic ideals of responsive leadership devolved into a system rigged by elite influence networks and tycoons? The tragic arc of the opioid crisis lends credence to critiques of America as a plutocracy masquerading as a republic.

As the opioid catastrophe escalated, responses from political leaders long paid to ignore warning signs ranged from tepid to complicit. Despite constituencies being decimated, many avoided policies that could curb profits, like prosecuting company leaders or funding treatment. Belated emergency decrees provided cover while avoiding real accountability. Opioid makers still reap billions in profits after paying settlements trivial relative to the scale of harms inflicted.

This sordid history raises skepticism about entrusting crisis response solely to the perpetrators and enablers who incubated the epidemic. Their pledges to make amends now ring hollow absent owning responsibility. Meaningful reforms appear necessary to constrain corporate power and corrupt elite influence that subordinate public welfare to private interests. Americans shaken by this nightmarish episode may conclude the institutions are too compromised to self-correct and must be redeemed through progress over plutocracy.

The merciless human toll of America's opioid plague spotlights endemic corruption of governing systems by moneyed special interests. This ongoing public health disaster was spawned by the callous pursuit of profit, enabled by regulatory surrender in the face of lobbying might. The scheme engorged the coffers of opioid makers while crushing families, communities, and faith in leaders. Its immense costs lay bare the moral bankruptcy of institutions serving the privileged few at such grievous public expense.

Redeeming civic promise requires truth, justice and change. The powerful must be held to account, balance restored to governance, and public interest reinstalled over private enrichment. For generations, the opioid crisis will be remembered as either the nadir spurring renewal, or another chapter of eroding trust as elites escape consequences. Its lessons must shape the necessary reckoning ahead to reclaim democracy from moneyed interests and reaffirm that all lives matter over lobbyists. In such a colossal crisis and tragedy, any attempt to shift blame onto others is an unforgivable crime of deceiving the American people.

The author is a Beijing-based commentator. The views don't necessarily reflect those of China Daily.

If you have a specific expertise, or would like to share your thought about our stories, then send us your writings at opinion@chinadaily.com.cn or comment@chinadaily.com.cn.

 

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    日本精品福利视频| 欧美wwwwwww| 天堂av2020| 国产二区视频在线播放| 亚洲女人在线观看| 欧美精品一区二区三区免费播放| 三级黄色片免费观看| 毛片av免费在线观看| 激情六月天婷婷| 成人黄色一级大片| 日韩 欧美 高清| 国产玉足脚交久久欧美| 午夜免费一级片| 一区二区在线播放视频| 欧美三级在线观看视频| 一二三四中文字幕| 日韩成人精品视频在线观看| av网站在线观看不卡| 国产一区 在线播放| 热久久久久久久久| 久久综合伊人77777麻豆最新章节| 男人添女荫道口喷水视频| 中文字幕色网站| 欧美性猛交久久久乱大交小说 | www.国产在线视频| 黄色一级片网址| 亚洲免费999| 精品日韩久久久| 无遮挡又爽又刺激的视频| 黄色大片中文字幕| 国产无限制自拍| 成人短视频在线观看免费| 欧美少妇一级片| 久久精品一卡二卡| 17c国产在线| 成年网站免费在线观看| 国产 porn| 另类小说第一页| 亚洲乱码国产一区三区| 久久国产色av免费观看| 亚洲乱码中文字幕久久孕妇黑人| 青青草精品视频在线| 国产a级片网站| 野外做受又硬又粗又大视频√| 久久久久久av无码免费网站下载| www.黄色网址.com| 4444亚洲人成无码网在线观看| 色乱码一区二区三区熟女| 色男人天堂av| 最新中文字幕久久| 国产激情片在线观看| 日韩一二区视频| 国产va亚洲va在线va| 精品少妇在线视频| 99精品视频在线看| 亚洲免费av一区二区三区| 国产一二三四在线视频| 老司机午夜性大片| 久久精品国产精品亚洲精品色| 9l视频自拍9l视频自拍| 日本一级淫片演员| 黄色一级片国产| www.日本少妇| 欧美 日韩 国产一区| 成人中文字幕av| 超碰成人在线播放| 久久免费一级片| 成人免费播放器| 蜜臀av午夜一区二区三区| 天堂网在线免费观看| 一本—道久久a久久精品蜜桃| 亚洲自拍偷拍一区二区三区| 91免费国产精品| 欧美女人性生活视频| 杨幂毛片午夜性生毛片| 国产91av视频在线观看| 日韩欧美不卡在线| 久久精品影视大全| mm131午夜| 欧美二区在线视频| 四季av一区二区三区| 国产香蕉一区二区三区| 免费av观看网址| 天堂在线中文在线| 日韩黄色片在线| 免费看黄色一级大片| 7777在线视频| 亚洲精品无码久久久久久| caoporm在线视频| 美脚丝袜脚交一区二区| 亚洲色图 在线视频| 久久久久久久久网| 日韩视频免费在线播放| 国产资源第一页| 欧美xxxxx在线视频| 韩国一区二区在线播放| 免费在线观看亚洲视频 | 美女扒开大腿让男人桶| 无码内射中文字幕岛国片| 在线观看视频黄色| 日本在线观看a| 黄色网zhan| 啊啊啊国产视频| 大西瓜av在线| 中文字幕日韩久久| 久久久久久久久久久久久久国产| 99精品视频网站| 动漫av免费观看| 国产精品久久久久久久乖乖| 日本 片 成人 在线| 日本人体一区二区| 国产精品中文久久久久久| 亚洲精品无码久久久久久| 国产经典久久久| 色免费在线视频| 六月丁香婷婷激情| 青青青在线观看视频| 污污的网站免费| 超碰网在线观看| 激情小视频网站| 7777在线视频| 制服丝袜中文字幕第一页 | 狠狠干视频网站| av亚洲天堂网| 99999精品视频| www成人免费| www.久久com| 中文字幕亚洲乱码| 欧美综合在线观看视频| 2018日日夜夜| 久久久久久久久久伊人| 亚洲五月激情网| 黄色小视频免费网站| 久久精品网站视频| 红桃av在线播放| 久久久久久久中文| 黄色一级在线视频| 久艹在线免费观看| www.亚洲成人网| 免费成人深夜夜行网站视频| 天天综合天天添夜夜添狠狠添| 黄色片在线免费| 成年人视频网站免费观看| 无码 制服 丝袜 国产 另类| mm131午夜| 欧美三级午夜理伦三级老人| www激情五月| www.日本久久| 182午夜视频| 国产福利精品一区二区三区| 亚洲综合欧美在线| 国产精品区在线| 最新天堂在线视频| 一级黄色在线播放| 成年人免费观看的视频| www.桃色.com| 国产又爽又黄ai换脸| 99热这里只有精品7| 中国老女人av| 日本a在线天堂| 欧美男女爱爱视频| 99爱视频在线| 已婚少妇美妙人妻系列| mm1313亚洲国产精品无码试看| 成年人视频在线免费| 国产精品天天av精麻传媒| 日本在线观看免费视频| 国产又粗又长又大的视频| 午夜免费高清视频| 午夜免费一级片| 日本一二三区视频在线| 日本熟妇人妻xxxx| 国产在线青青草| 日本一本草久p| 97在线免费视频观看| 国产精品www在线观看| 国产av国片精品| 久久午夜夜伦鲁鲁一区二区| 色播五月综合网| 特黄特黄一级片| 精品人妻少妇一区二区| 久久久久久久激情| 一本色道久久亚洲综合精品蜜桃| 色综合五月婷婷| 17c丨国产丨精品视频| 亚洲中文字幕无码专区| 午夜在线观看av| 国产一二三四五| 内射国产内射夫妻免费频道| av免费网站观看| 亚洲一级片免费观看| 国产av人人夜夜澡人人爽麻豆| 欧洲av无码放荡人妇网站| 色呦色呦色精品| 国产成人艳妇aa视频在线| 妞干网在线免费视频| 性欧美在线视频| 国产一二三在线视频| 美女喷白浆视频| 奇米777四色影视在线看|